Show
Sort by
-
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)
-
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
- Journal Article
- A1
- open access
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
Emergence of new ALK mutations at relapse of neuroblastoma
-
Genomic classification according to numerical and segmental chromosome instabilities is of strong prognostic relevance in neuroblastoma